Romero-Farina Guillermo, Aguadé-Bruix Santiago, Ferreira-González Ignacio
Nuclear Cardiology Unit, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona.
Centro de investigación biomédica en red: enfermedades cardiovasculares (CIBER-CV).
Nucl Med Commun. 2025 Jan 1;46(1):28-37. doi: 10.1097/MNM.0000000000001921. Epub 2024 Oct 31.
Evaluating the predictive models (PM) for a major adverse cardiac event (MACE) only in women with abnormal summed difference score (SDS ≥ 1), borderline myocardial ischemia (borderline-MIsch: SDS = 1), MIsch (SDS ≥ 2), mild-MIsch (SDS = 2-4), and moderate-severe MIsch (ms-MIsch: SDS ≥ 5).
Between January 2000 and January 2018, of 25 943 consecutive patients who underwent gated single-photon emission computed tomography myocardial perfusion imaging (gSPECT-MPI) for coronary risk stratification; 717 women (age 68.37 ± 3.4 years) with an abnormal SDS ≥ 1 were included. During the follow-up (mean 4 ± 2.9 years) post-gSPECT-MPI, MACE (unstable angina, nonfatal myocardial infarction, coronary revascularization, cardiac death) was assessed.
In the global women cohort with abnormal SDS ( n = 717), the PM was angina [hazard ratio (HR): 1.65, P = 0.016], diabetes (HR: 1.72, P = 0.004), beta-blockers (HR: 1.61, P = 0.009), pharmacological stress (HR: 1.74, P = 0.007), ↓ segment (ST) mm ≥ 1 (HR: 1.54, P = 0.039), and moderate-to-severe abnormal summed stress score (ms-SSS) (HR: 2.92, P = 0.001). In borderline-MIsch group ( n = 208), the PM was previous myocardial infarction (HR: 3.8, P = 0.001), nitrates (HR: 2.13, P = 0.047), pharmacological stress (HR: 4.81, P < 0.001), and ↓ST mm ≥ 1 (HR: 3.07, P = 0.014). In MIsch group ( n = 509), the PM model was ms-SSS (HR: 2.25, P = 0.001), diabetes (HR: 1.73, P = 0.011), angina (HR: 1.68, P = 0.029), beta-blockers (HR: 1.59, P = 0.026), and ms-MIsch (HR: 1.62, P = 0.044). In mild-MIsch group ( n = 399), the PM was ms-SSS (HR: 2.55, P = 0.003), diabetes (HR: 2.17, P = 0.004), angina (HR: 1.89, P = 0.037), and beta-blockers (HR: 2.01, P = 0.011). In ms-MIsch group ( n = 110), the predictive variable for MACE was ms-SSS (HR: 2.27, P = 0.016). The ms-SSS significantly increases the prognostic value of the ms-MIsch ( P = 0.001).
Women with different degrees of abnormal SDS have different PMs of MACE. The ms-SSS stands out as the most significant predictive variable.
仅在总和差异评分异常(SDS≥1)、临界心肌缺血(临界-MIsch:SDS = 1)、MIsch(SDS≥2)、轻度-MIsch(SDS = 2 - 4)和中度-重度MIsch(ms-MIsch:SDS≥5)的女性中评估主要不良心脏事件(MACE)的预测模型(PM)。
2000年1月至2018年1月期间,在连续25943例接受门控单光子发射计算机断层扫描心肌灌注成像(gSPECT-MPI)进行冠状动脉风险分层的患者中;纳入了717例SDS≥1异常的女性(年龄68.37±3.4岁)。在gSPECT-MPI后的随访(平均4±2.9年)期间,评估MACE(不稳定型心绞痛、非致命性心肌梗死、冠状动脉血运重建、心源性死亡)。
在SDS异常的全球女性队列(n = 717)中,PM为心绞痛[风险比(HR):1.65,P = 0.016]、糖尿病(HR:1.72,P = 0.004)、β受体阻滞剂(HR:1.61,P = 0.009)、药物负荷试验(HR:1.74,P = 0.007)、ST段压低(↓ST)≥1mm(HR:1.54,P = 0.039)以及中度至重度异常总和负荷评分(ms-SSS)(HR:2.92,P = 0.001)。在临界-MIsch组(n = 208)中,PM为既往心肌梗死(HR:3.8,P = 0.001)、硝酸盐类药物(HR:2.13,P = 0.047)、药物负荷试验(HR:4.81,P < 0.001)以及↓ST≥1mm(HR:3.07,P = 0.014)。在MIsch组(n = 509)中,PM模型为ms-SSS(HR:2.25,P = 0.001)、糖尿病(HR:1.73,P = 0.011)、心绞痛(HR:1.68,P = 0.029)、β受体阻滞剂(HR:1.59,P = 0.026)以及ms-MIsch(HR:1.62,P = 0.044)。在轻度-MIsch组(n = 399)中,PM为ms-SSS(HR:2.55,P = 0.003)、糖尿病(HR:2.17,P = 0.004)、心绞痛(HR:1.89,P = 0.037)以及β受体阻滞剂(HR:2.01,P = 0.011)。在ms-MIsch组(n = 110)中,MACE的预测变量为ms-SSS(HR:2.27,P = 0.016)。ms-SSS显著增加了ms-MIsch的预后价值(P = 0.001)。
不同程度SDS异常的女性有不同的MACE预测模型。ms-SSS是最显著的预测变量。